Clinical Trials Browser

Phase 3 × INDUSTRY × vorolanib × Clear all

NCT03095040 2021-02-08

CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma

Phase 3 Unknown

Renal Cell Cancer Metastatic